[Form 4] Zomedica Corp. Insider Trading Activity

Rhea-AI Filing Summary

Zomedica Corp. (ZOMDF)11/17/2025, reporting person Johnny Powers acquired 1,823,107 stock appreciation rights, each linked to one share of Zomedica common stock. The rights have a conversion or exercise price of $0.10 per share, with a vesting or exercisability date of 11/16/2026 and an expiration date of 11/16/2035. Following this grant, Powers beneficially owns 1,823,107 derivative securities directly, giving him economic exposure to the same number of Zomedica common shares if the stock price rises above the exercise price.

11/18/2025 - 04:45 PM

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

POWERS JOHNNY D

(Last) (First) (Middle)

1101 TECHNOLOGY DRIVE, STE 100

(Street)

ANN ARBOR MI 48108

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Zomedica Corp. [ ZOMDF ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
11/17/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Stock Appreciation Right	$0.1	11/17/2025		A		1,823,107		11/16/2026	11/16/2035	Common	1,823,107	$0	1,823,107	D

Explanation of Responses:

	/s/ Johnny Powers	11/17/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider transaction did Zomedica (ZOMDF) report for Johnny Powers?

Zomedica reported that director Johnny Powers acquired 1,823,107 stock appreciation rights on 11/17/2025, giving him derivative exposure to Zomedica common shares.

What is the exercise price of the stock appreciation rights reported by Zomedica (ZOMDF)?

The stock appreciation rights granted to Johnny Powers carry a conversion or exercise price of $0.10 per underlying share of Zomedica common stock.

When do Johnny Powers’ Zomedica (ZOMDF) stock appreciation rights become exercisable and when do they expire?

The stock appreciation rights become exercisable on 11/16/2026 and have an expiration date of 11/16/2035, providing a long-term equity incentive window.

How many derivative securities does Johnny Powers own in Zomedica (ZOMDF) after this transaction?

Following the reported transaction, Johnny Powers beneficially owns 1,823,107 derivative securities, all held in the form of stock appreciation rights.

What type of derivative security was granted to the Zomedica (ZOMDF) director?

The filing identifies the instrument as a Stock Appreciation Right, with each right tied to one share of Zomedica common stock as the underlying security.

Is the Zomedica (ZOMDF) Form 4 filed by one reporting person or multiple insiders?

The Form 4 is indicated as being filed by one reporting person, reflecting transactions solely for Johnny Powers.